🟢 Context Therapeutics is trading 5.68% up today in pre-market on stronger U.S. equity futures

Context Therapeutics is trading at $0.39, up +5.68% in pre-market amid broader risk-on conditions.

• No new company-specific announcement, earnings release, or regulatory catalyst was identified for September 21, 2026.
• Stronger U.S. equity futures and favorable overnight global sentiment appear consistent with the move, though reliable reporting does not directly attribute it.
• The September 9 CT-202 trial update is earlier context, not a fresh catalyst.